Innovative methods to evaluate the role of influenza vaccines in attenuating severe disease in adults
Ended Definitive Contract Awarded Last action
- Contract number
- 75D30120C07637
- Awardee
-
Vanderbilt University Medical Center UEI GYLUH9UXHDX5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $4,826,942
Award facts
- Opportunity
-
- Center for Disease Control FY 20 Broad Agency Announcement Pre-Solicitation · 75D30120R67946 · Posted Nov 7, 2019
- Center for Disease Control FY 20 Broad Agency Announcement Award Notice · Posted Apr 14, 2020
- Contract value 100% obligated
- $4,826,941.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 622110 General Medical and Surgical Hospitals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Nashville, TN 37232, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,826,942 |
About this award
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $4.8 million definitive contract to Vanderbilt University Medical Center to conduct research titled "Innovative Methods to Evaluate the Role of Influenza Vaccines in Attenuating Severe Disease in Adults." The prime contractor will lead a network of 16 academic medical centers as subcontractors to study the effectiveness of influenza vaccines in preventing critical illness. This award was made under a $28 million Broad Agency Announcement seeking white papers related to preventing and controlling infectious diseases. The prime contractor will serve as the clinical coordinating center, data coordinating center, central laboratory, and single Institutional Review Board, overseeing three COVID-19 related studies in addition to future portfolio studies. Performance will take place at locations of the prime contractor and subcontractors.
Quick answers
Who was awarded contract 75D30120C07637?
75D30120C07637 was awarded to Vanderbilt University Medical Center by CDC Pittsburgh (Centers for Disease Control and Prevention) on March 26, 2020.
How much is contract 75D30120C07637 worth?
The government has obligated $4,826,942 on 75D30120C07637.
Was contract 75D30120C07637 competed?
The extent of competition for 75D30120C07637 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award